Promising clinical results for innovative mutated anti-EGFR radiotracer in patients with non-small cell lung cancer 18/12/17 DOWNLOAD
Oncodesign announces positive results opening the way for the ALK1 program to advance to the lead optimization phase 15/11/17 DOWNLOAD